Articles by Lim Jeong-yeo
-
![[Herald Interview] Carbon-neutral Philips sets higher goals for 2025](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/03/01/20210301000168_0.jpg)
[Herald Interview] Carbon-neutral Philips sets higher goals for 2025IndustryMar 1, 2021For anyone who has tried, it is evident that reducing one’s carbon footprint requires an extraordinary attention to the waste produced, coupled with a conscious effort to cut down on convenient habit... -
GC WellBeing to repurpose liver drug as COVID-19 treatmentIndustryFeb 26, 2021GC WellBeing will conduct a phase 2 clinical trial of its liver drug Laennec, to repurpose it as a COVID-19 treatment, the Ministry of Food and Drug Safety said Friday. This puts the total count of ... -
Pfizer vaccine approval in Korea imminent, FDA allows more flexible storageIndustryFeb 26, 2021South Korea on Friday paved the way to approving Pfizer’s mRNA vaccine for COVID-19 as another group of pharmaceutical experts positively opined on the vaccine’s efficacy and safety. On the same day... -
EMA starts rolling review of Celltrion’s COVID-19 treatmentIndustryFeb 25, 2021European Medicines Agency said Wednesday, local time, that it has started a “rolling review” of data on South Korean company Celltrion’s monoclonal antibody regdanvimab. Regdanvimab, also known as C... -
Christopher Ko shares visions as Bio association representativeIndustryFeb 24, 2021South Korean biosimilar maker Samsung Bioepis’ CEO Christopher Ko on Wednesday carried out his first public event as the new chairperson of the Korea Bio Association. Korea Bio is an association rep... -
Elekta’s next-gen MRI device offers new hope for cancer patientsIndustryFeb 24, 2021Swedish medical device company Elekta wants to give renewed hopes to cancer patients through its next-generation radiotherapy device Unity. Elekta on Wednesday launched Unity in Korea, making it the... -
Korean experts advise Pfizer vaccine for 16 and olderIndustryFeb 23, 2021The first of the three-part evaluation of Pfizer’s COVID-19 vaccine here has shown the vaccine to be 95 percent effective and eligible for use on those aged 16 and older, South Korea’s Drug Ministry ... -
![[Herald Interview] Software dons role of therapeutics](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/22/20210222000670_0.jpg)
[Herald Interview] Software dons role of therapeuticsIndustryFeb 22, 2021When talking about medical devices, conventional hardware with analytical or therapeutic functions for human health usually come to mind. But computer software that seeks to cure or alleviate sympto... -
Macrogen, Lifex Biolabs to research Parkinson’s treatmentIndustryFeb 22, 2021Precision life science company Macrogen will collaborate with US-based Lifex Biolabs on Parkinson’s disease treatment research, Macrogen announced Monday. This is a follow-up to Macrogen’s strategic... -
Samsung Display joins responsible business allianceIndustryFeb 21, 2021Samsung Display’s chief executive officer Choi Joo-sun is aiming to further embolden the company’s environmental, social and governance (ESG) involvement beginning this year. As part of this drive, ... -
Celltrion to take on S. Africa variantIndustryFeb 18, 2021Only a day after Celltrion began distribution of its monoclonal antibody therapy for COVID-19 in Korea, the company announced Thursday that it is setting out to tackle the more contagious South Afric... -
Celltrion begins distribution of COVID-19 therapy in KoreaIndustryFeb 17, 2021Celltrion began nationwide distribution of its monoclonal antibody therapy for COVID-19 on Wednesday. Celltrion’s regdanvimab is Korea’s first emergency-approved COVID-19 treatment. All 156 state-d... -
![[News Focus] More homegrown COVID-19 therapies coming](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/16/20210216000844_0.jpg)
[News Focus] More homegrown COVID-19 therapies comingIndustryFeb 16, 2021Following Celltrion’s monoclonal antibody treatment for COVID-19, a slew of homegrown therapies is on the way in the first half of 2021. Chong Kun Dang Pharmaceutical is set to submit application fo... -
SK Bioscience to manufacture Novavax vaccine for 20 mil populationIndustryFeb 16, 2021South Korean vaccine-maker SK Bioscience will manufacture 40 million doses of US’ Novavax vaccines, enough to inoculate 20 million people. Under the agreement signed by SK Bioscience, Korea Disease ... -
Celltrion’s Humira biosimilar gains European sales approvalIndustryFeb 15, 2021Celltrion’s Yuflyma, an adalimumab biosimilar for autoimmune diseases, has been given the green light by the European Commission on Feb. 11, allowing for it to be sold in the European market, Celltri...
MOST POPULAR
-
01Moon to meet Pfizer CEO in New York
-
New cases slightly over 1,700; concerns grow over further spread after Chuseok holiday02
-
03S. Korea, Britain discuss vaccine swap in summit
-
New cases slightly over 1,600; concerns grow over further spread after Chuseok holiday04
-
05[Photo News] Apple unveils new lineup for 2021
-
From vaccination reminders to relief aid info: Virtual assistant helps over 12m residents06
-
07N. Korea downplays S. Korea’s SLBM test
-
BTS praises youth for welcoming challenges of COVID-19 pandemic08
-
09Ruling party leader says Biden vague on NK
-
[Photo News] Blooming buckwheat flowers in Bongpyeong10